To rule out that this growth delay was caused by a direct effect of the treatment on the tumor, we implanted B16 tumors in immunodeficient non-obese diabetic (NOD)/severe combined immunodeficiency (SCID)/IL-2Rγ-null mice (NSG). The gene discussed is IL2RG; the disease is neoplasm.